Halozyme
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
12390 El Camino Real, San Diego, Califor...Phone Number
(858) 794-8889Website
www.halozyme.comRevenue
$1.5 BillionStock Symbol
HALOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
5
1
2
1
1
About Halozyme
Halozyme Inc. is an American biotechnology and biopharmaceutical company specializing in the development and commercialization of advanced drug delivery technologies and enzyme-based therapeutic solutions. The organization focuses primarily on improving the administration of biologic medicines through proprietary technologies that enable subcutaneous drug delivery for therapies that traditionally require intravenous infusion. Through scientific innovation, strategic pharmaceutical partnerships, and proprietary platform technologies, the company has established a significant position within the global biotechnology and pharmaceutical ecosystem. The company was founded in San Diego, California and has evolved into a globally recognized biotechnology enterprise with extensive collaborations across the pharmaceutical industry. Halozymes business model combines internal therapeutic development with technology licensing arrangements that allow pharmaceutical partners to integrate Halozymes pRead more
Halozyme Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Halozyme your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Halozyme
Check if Halozyme has recently received funding, and reach out quickly before it becomes old news!
Click to see if Halozyme had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Halozyme has new funding data
Check out if Halozyme is spiking on competitors!
Earning: See what the market has to say on Halozyme recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Halozyme, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Halozyme launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Halozyme as Masked Content
Find more new buyers
Compare Similar Companies to Halozyme
Compare insights from companies similar to Halozyme, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$19.9M
51-200
Private
$300M
2016
RC
Ryan CarteExecutive Vice President & General Counsel & Corporate Secretary
$18.1M
501-1,000
Public
$100M
2008
RM
Rafael MarinoAffairs Operations Senior Director, Medical & Chief of Staff
Company Profile Activity
Activity Insights
Halozyme is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Halozyme is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Halozyme.
Halozyme financials insights
Gather financial insights about Halozyme, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Corporate Investment
$5.5M
Stock Offering
$38.2M
2010
Stock Offering
$60M
2012
Stock Offering
$81.8M
2014
Debt
$50M
Stock Offering
$107.8M
2016
Debt
$150M
2017
Stock Offering
$135M
2019
Debt
$400M
Halozyme Tech Stack
A closer look at the technologies used by Halozyme
See more technologies
Most Recent Scoops
Open Position
Partnership
Project
Partnership, Product Development, Business Development, Intellectual Property, Legal Affairs, Bioengineering, Medical Research
Person-Based
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Halozyme News & Media
Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today
Shares of biopharmaceutical drug delivery company Halozyme Therapeutics (NASDAQ:HALO) jumped 5.2% in the afternoon session after an analyst reiterated a Buy rating on the stock, and a partner company, argenx, presented positive new data for a drug that utilizes Halozyme's technology.Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Halozyme Therapeutics (NASDAQ:HALO) and the rest of the therapeutics stocks fared in Q1.Halozyme Therapeutics (HALO) Announces Global Collaboration and License Agreement With GSK
Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the best healthcare stocks to buy for the long term. Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced on May 7 that the company entered into a global collaboration and license agreement with GSK, under which GSK has licensed Halozyme’s ENHANZE® drug delivery technology for the development and potential commercialization of […]HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE
Announcing New $1 billion Share Repurchase Program Projecting to Buy Back at Least $400 million in 2026 Total Revenue Increased 42% YOY to $377 million Royalty Revenue Increased 43% YOY to $241 million Reiterating 2026 Financial Guidance Ranges: Total Revenue of $1.710 - $1.810 billion,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Halozyme
Sign Up For FreeTo access detailed company insights
Halozyme Inc. is an American biotechnology and biopharmaceutical company specializing in the development and commercialization of advanced drug delivery technologies and enzyme-based therapeutic solutions. The organization focuses primarily on improving the administration of biologic medicines through proprietary technologies that enable subcutaneo... Read More
